Innovative Rfk SpA

Research Innovative Rfk SpA (MLIRF) on Bullrun: market cap EUR 18.88M, P/E 13.6. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 18.88M; P/E is 13.6.

Peer valuation comparison

Latest P/E is 13.55x versus a Financial Services sector median of 13.84x (2.1% below).

Latest P/E is 13.55x versus a Italy median of 17.69x (23.4% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 388.14KEUR 1.39M-EUR 656.60K99.3%n/aEUR 972.93KEUR 1.16MEUR 12.92M
FY2024EUR 255.38KEUR 1.16MEUR 479.84K61.0%n/aEUR 129.26KEUR 1.82MEUR 13.32M
FY2023EUR 130.82K-EUR 841.24K-EUR 464.06K30.1%-0.07EUR 663.84KEUR 1.82MEUR 14.68M
FY2022EUR 118.89KEUR 1.93M-EUR 396.33K93.6%0.17EUR 7.60MEUR 1.85MEUR 15.62M
FY2021EUR 60.07K-EUR 343.35K-EUR 168.41K88.5%-0.04EUR 1.60MEUR 1.85MEUR 10.31M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-23EUR 18.88M13.6n/an/a

About Innovative Rfk SpA

Innovative-RFK S.p.A. is a private equity firm specializing in growth capital investments in Small and Medium sized companies. The firm prefers to make small cap buy-outs. The firm also makes fund of fund investments in private equity funds. It prefers to invest in the biomedical systems, microcredit for SMEs, information technology, high tech sector, and innovative solutions for different industries. It typically invests in companies based in Italy.

Related stock research

Other Financial Services stocks

Frequently asked questions

What is Innovative Rfk SpA's market cap?

Innovative Rfk SpA's market capitalization is EUR 18.88M.

What is Innovative Rfk SpA's P/E ratio?

Innovative Rfk SpA's price-to-earnings (P/E) ratio is 13.6.

What does Innovative Rfk SpA do?

Innovative-RFK S.p.A. is a private equity firm specializing in growth capital investments in Small and Medium sized companies. The firm prefers to make small cap buy-outs. The firm also makes fund of fund investments in private equity funds. It prefers to invest in the biomedical systems, microcredit for SMEs, information technology, high tech sector, and innovative solutions for different industries. It typically invests in companies based in Italy.